Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Characterization of the binding site for d-deprenyl in human inflamed synovial membrane.

Lesniak A, Aarnio M, Diwakarla S, Norberg T, Nyberg F, Gordh T.

Life Sci. 2018 Feb 1;194:26-33. doi: 10.1016/j.lfs.2017.12.003. Epub 2017 Dec 5.

PMID:
29221756
2.

Risk Mapping of Groundwater-Drawdown-Induced Land Subsidence in Heterogeneous Soils on Large Areas.

Sundell J, Haaf E, Norberg T, Alén C, Karlsson M, Rosén L.

Risk Anal. 2017 Oct 30. doi: 10.1111/risa.12890. [Epub ahead of print]

PMID:
29084353
3.

Expert elicitation for deriving input data for probabilistic risk assessment of shipwrecks.

Landquist H, Norrman J, Lindhe A, Norberg T, Hassellöv IM, Lindgren JF, Rosén L.

Mar Pollut Bull. 2017 Dec 15;125(1-2):399-415. doi: 10.1016/j.marpolbul.2017.09.043. Epub 2017 Sep 29.

PMID:
28969906
4.

High-affinity recognition of the human C-reactive protein independent of phosphocholine.

Yang J, Gustavsson AL, Haraldsson M, Karlsson G, Norberg T, Baltzer L.

Org Biomol Chem. 2017 May 31;15(21):4644-4654. doi: 10.1039/c7ob00684e.

PMID:
28513744
5.

Bayesian updating in a fault tree model for shipwreck risk assessment.

Landquist H, Rosén L, Lindhe A, Norberg T, Hassellöv IM.

Sci Total Environ. 2017 Jul 15;590-591:80-91. doi: 10.1016/j.scitotenv.2017.03.033. Epub 2017 Mar 15.

PMID:
28314157
6.

High-throughput screening and radioligand binding studies reveal monoamine oxidase-B as the primary binding target for d-deprenyl.

Lesniak A, Aarnio M, Jonsson A, Norberg T, Nyberg F, Gordh T.

Life Sci. 2016 May 1;152:231-7. doi: 10.1016/j.lfs.2016.03.058. Epub 2016 Apr 5.

PMID:
27058977
7.

A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway.

Tundup S, Srivastava L, Norberg T, Watford W, Harn D.

PLoS One. 2015 Sep 4;10(9):e0137495. doi: 10.1371/journal.pone.0137495. eCollection 2015.

8.

Cost-benefit analysis as a part of sustainability assessment of remediation alternatives for contaminated land.

Söderqvist T, Brinkhoff P, Norberg T, Rosén L, Back PE, Norrman J.

J Environ Manage. 2015 Jul 1;157:267-78. doi: 10.1016/j.jenvman.2015.04.024. Epub 2015 Apr 24.

PMID:
25913468
9.

SCORE: a novel multi-criteria decision analysis approach to assessing the sustainability of contaminated land remediation.

Rosén L, Back PE, Söderqvist T, Norrman J, Brinkhoff P, Norberg T, Volchko Y, Norin M, Bergknut M, Döberl G.

Sci Total Environ. 2015 Apr 1;511:621-38. doi: 10.1016/j.scitotenv.2014.12.058. Epub 2015 Jan 13.

PMID:
25594905
10.

Incorporating expert judgments in utility evaluation of bacteroidales qPCR assays for microbial source tracking in a drinking water source.

Åström J, Pettersson TJ, Reischer GH, Norberg T, Hermansson M.

Environ Sci Technol. 2015 Feb 3;49(3):1311-8. doi: 10.1021/es504579j. Epub 2015 Jan 20.

11.

A fault tree model to assess probability of contaminant discharge from shipwrecks.

Landquist H, Rosén L, Lindhe A, Norberg T, Hassellöv IM, Lindgren JF, Dahllöf I.

Mar Pollut Bull. 2014 Nov 15;88(1-2):239-48. doi: 10.1016/j.marpolbul.2014.08.037. Epub 2014 Sep 18.

PMID:
25240740
12.

SF Box--a tool for evaluating the effects on soil functions in remediation projects.

Volchko Y, Norrman J, Rosén L, Norberg T.

Integr Environ Assess Manag. 2014 Oct;10(4):566-75. doi: 10.1002/ieam.1552.

PMID:
24903441
13.

Immunomodulatory glycan lacto-N-fucopentaose III requires clathrin-mediated endocytosis to induce alternative activation of antigen-presenting cells.

Srivastava L, Tundup S, Choi BS, Norberg T, Harn D.

Infect Immun. 2014 May;82(5):1891-903. doi: 10.1128/IAI.01293-13. Epub 2014 Feb 24.

14.

Using soil function evaluation in multi-criteria decision analysis for sustainability appraisal of remediation alternatives.

Volchko Y, Norrman J, Rosén L, Bergknut M, Josefsson S, Söderqvist T, Norberg T, Wiberg K, Tysklind M.

Sci Total Environ. 2014 Jul 1;485-486:785-791. doi: 10.1016/j.scitotenv.2014.01.087. Epub 2014 Feb 11.

PMID:
24529453
15.

A synthetic polypeptide conjugate from a 42-residue polypeptide and salicylhydroxamic acid binds human myeloperoxidase with high affinity.

Sun X, Yang J, Norberg T, Baltzer L.

J Pept Sci. 2012 Dec;18(12):731-9. doi: 10.1002/psc.2459. Epub 2012 Oct 19.

PMID:
23086900
16.

Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.

Zhu B, Trikudanathan S, Zozulya AL, Sandoval-Garcia C, Kennedy JK, Atochina O, Norberg T, Castagner B, Seeberger P, Fabry Z, Harn D, Khoury SJ, Guleria I.

Clin Immunol. 2012 Mar;142(3):351-61. doi: 10.1016/j.clim.2011.12.006. Epub 2011 Dec 30.

17.

Powerful protein binders from designed polypeptides and small organic molecules--a general concept for protein recognition.

Tegler LT, Nonglaton G, Büttner F, Caldwell K, Christopeit T, Danielson UH, Fromell K, Gossas T, Larsson A, Longati P, Norberg T, Ramapanicker R, Rydberg J, Baltzer L.

Angew Chem Int Ed Engl. 2011 Feb 18;50(8):1823-7. doi: 10.1002/anie.201005059. Epub 2011 Jan 14. No abstract available.

PMID:
21328648
18.

Cost-effectiveness analysis of risk-reduction measures to reach water safety targets.

Lindhe A, Rosén L, Norberg T, Bergstedt O, Pettersson TJ.

Water Res. 2011 Jan;45(1):241-53. doi: 10.1016/j.watres.2010.07.048. Epub 2010 Aug 3.

PMID:
20943244
19.

Fault tree analysis for integrated and probabilistic risk analysis of drinking water systems.

Lindhe A, Rosén L, Norberg T, Bergstedt O.

Water Res. 2009 Apr;43(6):1641-53. doi: 10.1016/j.watres.2008.12.034. Epub 2009 Jan 3.

PMID:
19157488
20.

Value of information analysis in remedial investigations.

Back PE, Rosén L, Norberg T.

Ambio. 2007 Sep;36(6):486-93.

PMID:
17985703
21.

Glycosylated foldamers: synthesis of carbohydrate-modified beta3hSer and incorporation into beta-peptides.

Norgren AS, Norberg T, Arvidsson PI.

J Pept Sci. 2007 Nov;13(11):717-27.

PMID:
17890640
22.

Pathogen specific carbohydrate antigen microarrays: a chip for detection of Salmonella O-antigen specific antibodies.

Blixt O, Hoffmann J, Svenson S, Norberg T.

Glycoconj J. 2008 Jan;25(1):27-36. Epub 2007 Jun 9.

PMID:
17558551
23.

Sequencing of the tumor suppressor gene TP 53.

Linderholm B, Norberg T, Bergh J.

Methods Mol Med. 2006;120:389-401.

PMID:
16491613
24.

Chemical synthesis of analogs of the glycopeptide contulakin-G, an analgetically active conopeptide from Conus geographus.

Westerlind U, Norberg T.

Carbohydr Res. 2006 Jan 16;341(1):9-18. Epub 2005 Dec 1.

PMID:
16325161
25.

Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.

Eklund EA, Merbouh N, Ichikawa M, Nishikawa A, Clima JM, Dorman JA, Norberg T, Freeze HH.

Glycobiology. 2005 Nov;15(11):1084-93. Epub 2005 Aug 3.

PMID:
16079417
26.
27.

Synthesis of deoxy and acylamino derivatives of lactose and use of these for probing the active site of Neisseria meningitidis N-acetylglucosaminyltransferase.

Westerlind U, Hagback P, Tidbäck B, Wiik L, Blixt O, Razi N, Norberg T.

Carbohydr Res. 2005 Feb 7;340(2):221-33.

PMID:
15639242
28.

Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post-translationally modified conotoxin, reveals that the glycan structure is alpha-D-Gal-(1-->3)-alpha-D-GalNAc.

Kang J, Low W, Norberg T, Meisenhelder J, Hansson K, Stenflo J, Zhou GP, Imperial J, Olivera BM, Rigby AC, Craig AG.

Eur J Biochem. 2004 Dec;271(23-24):4939-49.

29.
30.

Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.

Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S, Holmberg L, Bergh J.

Carcinogenesis. 2004 Mar;25(3):375-80. Epub 2003 Nov 21.

PMID:
14633656
31.

Specificity of human anti-NOR antibodies, a distinct species of "natural" anti-alpha-galactosyl antibodies.

Duk M, Westerlind U, Norberg T, Pazynina G, Bovin NN, Lisowska E.

Glycobiology. 2003 Apr;13(4):279-84. Epub 2003 Jan 3.

PMID:
12626386
32.
33.

Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation.

Mahdavi J, Sondén B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, Altraja S, Wadström T, Kersulyte D, Berg DE, Dubois A, Petersson C, Magnusson KE, Norberg T, Lindh F, Lundskog BB, Arnqvist A, Hammarström L, Borén T.

Science. 2002 Jul 26;297(5581):573-8.

34.

(1)H NMR studies of hydroxy protons of the V[beta-Gal(1-->3)-alpha-GalNAc(1-->O)]THPGY glycopeptide.

Kindahl L, Sandström C, Norberg T, Kenne L.

Carbohydr Res. 2001 Dec 7;336(4):319-23.

PMID:
11728401
35.

Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.

Norberg T, Klaar S, Kärf G, Nordgren H, Holmberg L, Bergh J.

Cancer Res. 2001 Nov 15;61(22):8317-21.

36.

Solid-Phase Enzymatic Synthesis of a Sialyl Lewis X Tetrasaccharide on a Sepharose Matrix.

Blixt O, Norberg T.

J Org Chem. 1998 Apr 17;63(8):2705-2710.

PMID:
11672140
37.

Enzymatic mutation detection method evaluated for detection of p53 mutations in cDNA from breast cancers.

Norberg T, Klaar S, Lindqvist L, Lindahl T, Ahlgren J, Bergh J.

Clin Chem. 2001 May;47(5):821-8.

38.
39.

Hydroxy protons in conformational study of a Lewis b tetrasaccharide derivative in aqueous solution by NMR spectroscopy.

Bekiroglu S, Sandström C, Norberg T, Kenne L.

Carbohydr Res. 2000 Sep 22;328(3):409-18.

PMID:
11072848
40.

Synthesis of a spacer-containing disaccharide fragment of Bordetella pertussis lipopolysaccharide.

Nilsson M, Norberg T.

Carbohydr Res. 2000 Jul 24;327(3):261-7.

PMID:
10945674
42.
43.

Contulakin-G, an O-glycosylated invertebrate neurotensin.

Craig AG, Norberg T, Griffin D, Hoeger C, Akhtar M, Schmidt K, Low W, Dykert J, Richelson E, Navarro V, Mazella J, Watkins M, Hillyard D, Imperial J, Cruz LJ, Olivera BM.

J Biol Chem. 1999 May 14;274(20):13752-9.

44.

Reference values of facial features in Scandinavian children measured with a range-camera technique.

Strömland K, Chen Y, Norberg T, Wennerström K, Michael G.

Scand J Plast Reconstr Surg Hand Surg. 1999 Mar;33(1):59-65.

PMID:
10207966
46.

Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets.

Williams C, Norberg T, Ahmadian A, Pontén F, Bergh J, Inganäs M, Lundeberg J, Uhlén M.

Clin Chem. 1998 Mar;44(3):455-62.

47.

Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases.

Platz A, Sevigny P, Norberg T, Ring P, Lagerlöf B, Ringborg U.

Br J Cancer. 1996 Sep;74(6):936-41.

48.

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.

Sjögren S, Inganäs M, Norberg T, Lindgren A, Nordgren H, Holmberg L, Bergh J.

J Natl Cancer Inst. 1996 Feb 21;88(3-4):173-82.

PMID:
8632491
49.

Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53.

Norberg T, Jansson T, Sjøgren S, Mårtensson C, Andréasson I, Fjällskog ML, Lindman H, Nordgren H, Lindgren A, Holmberg L, Bergh J.

Acta Oncol. 1996;35 Suppl 5:96-102. Review.

PMID:
9142977
50.

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings.

Jansson T, Inganäs M, Sjögren S, Norberg T, Lindgren A, Holmberg L, Bergh J.

J Clin Oncol. 1995 Nov;13(11):2745-51.

PMID:
7595733

Supplemental Content

Loading ...
Support Center